{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:35:32Z","timestamp":1793900132796,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":463,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1093\/annonc\/mdy145","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T19:09:53Z","timestamp":1524164993000},"page":"iv126-iv142","source":"Crossref","is-referenced-by-count":156,"special_numbering":"S4","title":["Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines"],"prefix":"10.1016","volume":"29","author":[{"given":"P.","family":"Bossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Antonuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.I.","family":"Cherny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Rosengarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pernot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Trippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Snegovoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.I.","family":"Ripamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdy145_bb0010","unstructured":"Diarrhoeal Disease. Fact sheet N\u00b0330. World Health Organization. Updated May 2017. http:\/\/www.who.int\/mediacentre\/factsheets\/fs330\/en\/ (7 May 2018, date last accessed)."},{"key":"10.1093\/annonc\/mdy145_bb0015","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.ejca.2015.04.004","article-title":"Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: results from the population-based PROFILES registry","volume":"51","author":"Verhaar","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdy145_bb0020","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2015.65.7973","article-title":"Oncogastroenterology","volume":"34","author":"Grover","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0025","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","article-title":"How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30","volume":"22","author":"Fromme","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0030","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1200\/JCO.2007.12.4784","article-title":"Patient-reported outcomes and the evolution of adverse event reporting in oncology","volume":"25","author":"Trotti","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0035","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/cncr.24963","article-title":"Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer","volume":"116","author":"Chen","year":"2010","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdy145_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.clon.2011.03.006","article-title":"Can nurses manage gastrointestinal symptoms arising from pelvic radiation disease?","volume":"23","author":"Benton","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1093\/annonc\/mdy145_bb0045","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(13)61648-7","article-title":"Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial","volume":"382","author":"Andreyev","year":"2013","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdy145_bb0050","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S1470-2045(14)70006-3","article-title":"Guidance on the management of diarrhoea during cancer chemotherapy","volume":"15","author":"Andreyev","year":"2014","journal-title":"Lancet Oncol"},{"issue":"Suppl 4","key":"10.1093\/annonc\/mdy145_bb0055","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.cmi.2016.03.010","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection","volume":"22","author":"Crobach","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdy145_bb0060","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"issue":"Suppl. 4","key":"10.1093\/annonc\/mdy145_bb0065","doi-asserted-by":"crossref","first-page":"iv119","DOI":"10.1093\/annonc\/mdx225","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Haanen","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/2040622313496126","article-title":"Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance","volume":"4","author":"Sachdev","year":"2013","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1093\/annonc\/mdy145_bb0075","first-page":"106","article-title":"Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management","volume":"25","author":"Boussios","year":"2012","journal-title":"Ann Gastroenterol"},{"key":"10.1093\/annonc\/mdy145_bb0080","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1200\/JCO.1998.16.11.3537","article-title":"Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors","volume":"16","author":"Meta-Analysis Group In Cancer","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0085","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00384-004-0613-5","article-title":"The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients","volume":"19","author":"Yumuk","year":"2004","journal-title":"Int J Colorectal Dis"},{"key":"10.1093\/annonc\/mdy145_bb0090","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2000.18.6.1337","article-title":"Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study","volume":"18","author":"Van Cutsem","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.critrevonc.2017.12.010","article-title":"A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients","volume":"122","author":"Baratelli","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdy145_bb0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.critrevonc.2013.11.008","article-title":"Targeted therapy-induced diarrhea: a review of the literature","volume":"90","author":"Pessi","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdy145_bb0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/00365521.2010.545832","article-title":"\u201cPelvic radiation disease\u201d: new understanding and new solutions for a new disease in the era of cancer survivorship","volume":"46","author":"Andreyev","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1093\/annonc\/mdy145_bb0110","doi-asserted-by":"crossref","first-page":"383.","DOI":"10.1007\/s11894-014-0383-3","article-title":"Radiation enteritis","volume":"16","author":"Harb","year":"2014","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1093\/annonc\/mdy145_bb0115","first-page":"1771","article-title":"Acute effects of abdominopelvic irradiation on the orocecal transit time: its relation to clinical symptoms, and bile salt and lactose malabsorption","volume":"86","author":"Fern\u00e1ndez-Ba\u00f1ares","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1093\/annonc\/mdy145_bb0120","doi-asserted-by":"crossref","first-page":"e0178870","DOI":"10.1371\/journal.pone.0178870","article-title":"Probiotics for prevention of radiation-induced diarrhea: a meta-analysis of randomized controlled trials","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"key":"10.1093\/annonc\/mdy145_bb0125","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1128\/JCM.01280-09","article-title":"Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections","volume":"47","author":"Huang","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1093\/annonc\/mdy145_bb0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MOG.0b013e32834353cb","article-title":"Mechanisms, prevention, and management of diarrhea in enteral nutrition","volume":"27","author":"Whelan","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1093\/annonc\/mdy145_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1054\/clnu.2001.0399","article-title":"Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double-blind, randomized, and controlled trial","volume":"20","author":"Spapen","year":"2001","journal-title":"Clin Nutr"},{"key":"10.1093\/annonc\/mdy145_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0148607116673053","article-title":"ASPEN safe practices for enteral nutrition therapy","volume":"41","author":"Boullata","year":"2017","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1093\/annonc\/mdy145_bb0145","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/annonc\/mdu106","article-title":"The efficacy and safety of probiotics in people with cancer: a systematic review","volume":"25","author":"Redman","year":"2014","journal-title":"Ann Oncol"},{"issue":"Suppl 4","key":"10.1093\/annonc\/mdy145_bb0150","first-page":"iv1","article-title":"Guidelines for management of patients with a short bowel","volume":"55","author":"Nightingale","year":"2006","journal-title":"Gut"},{"key":"10.1093\/annonc\/mdy145_bb0155","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/codi.12932","article-title":"Are bile acid malabsorption and bile acid diarrhoea important causes of loose stool complicating cancer therapy?","volume":"17","author":"Phillips","year":"2015","journal-title":"Colorectal Dis"},{"key":"10.1093\/annonc\/mdy145_bb0160","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/codi.13767","article-title":"Defining low anterior resection syndrome: a systematic review of the literature","volume":"19","author":"Keane","year":"2017","journal-title":"Colorectal Dis"},{"key":"10.1093\/annonc\/mdy145_bb0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/JCO.2001.19.3.756","article-title":"Neutropenic enterocolitis in patients with acute leukemia: prognostic significance of bowel wall thickening detected by ultrasonography","volume":"19","author":"Cartoni","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0170","doi-asserted-by":"crossref","first-page":"e0184360","DOI":"10.1371\/journal.pone.0184360","article-title":"Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study","volume":"12","author":"Pearce","year":"2017","journal-title":"PLoS One"},{"key":"10.1093\/annonc\/mdy145_bb0175","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1200\/JCO.2004.04.132","article-title":"Recommended guidelines for the treatment of cancer treatment-induced diarrhea","volume":"22","author":"Benson","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpainsymman.2007.10.007","article-title":"Evaluation and management of treatment-related diarrhea in patients with advanced cancer: a review","volume":"36","author":"Cherny","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mdy145_bb0185","first-page":"15","article-title":"The role of loperamide in gastrointestinal disorders","volume":"8","author":"Hanauer","year":"2008","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1093\/annonc\/mdy145_bb0190","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00520-012-1658-6","article-title":"Supportive care and not only palliative care in the route of cancer patients","volume":"21","author":"Antonuzzo","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1093\/annonc\/mdy145_bb0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/CCO.0b013e328352eabc","article-title":"Supportive Care in Cancer Unit (SCCU) at the National Cancer Institute of Milan: a new integrated model of medicine in oncology","volume":"24","author":"Ripamonti","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0200","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/cis998","article-title":"Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy","volume":"56","author":"Nesher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1093\/annonc\/mdy145_bb0205","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1001\/jama.291.21.2628","article-title":"Scientific rationale for a change in the composition of oral rehydration solution","volume":"291","author":"Duggan","year":"2004","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdy145_bb0210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.30321","article-title":"Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity","volume":"123","author":"Ma","year":"2017","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdy145_bb0215","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1023\/A:1008390308416","article-title":"Substantial activity of budesonide in patients with irinotecan (CPT-11) and 5-fluorouracil induced diarrhea and failure of loperamide treatment","volume":"10","author":"Lenfers","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdy145_bb0220","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000086971","article-title":"Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer","volume":"68","author":"Karthaus","year":"2005","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdy145_bb0225","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s00520-015-2653-5","article-title":"Outcomes from treating bile acid malabsorption using a multidisciplinary approach","volume":"23","author":"Gupta","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1093\/annonc\/mdy145_bb0230","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1756283X10377126","article-title":"Managing bile acid diarrhoea","volume":"3","author":"Walters","year":"2010","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1093\/annonc\/mdy145_bb0235","first-page":"CD012529","article-title":"Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers","volume":"1","author":"Lawrie","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/annonc\/mdy145_bb0240","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpainsymman.2013.02.016","article-title":"Prevalence of symptoms in older cancer patients receiving palliative care: a systematic review and meta-analysis","volume":"47","author":"Van Lancker","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mdy145_bb0245","first-page":"380","article-title":"Glutamine for chemotherapy induced diarrhea: a meta-analysis","volume":"21","author":"Sun","year":"2012","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1093\/annonc\/mdy145_bb0250","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MEG.0000000000000833","article-title":"Diarrhea after allogeneic stem cell transplantation: beyond graft-versus-host disease","volume":"29","author":"Robak","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1093\/annonc\/mdy145_bb0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","article-title":"Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"33","author":"Dykewicz","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419316941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419316941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/29\/Supplement_4\/iv126\/25899749\/mdy145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:47:42Z","timestamp":1624697262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419316941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":50,"alternative-id":["S0923753419316941"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdy145","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}